Xcelris Genomics

Ahmedabad, India Founded: 2005 • Age: 21 yrs
Delivers comprehensive services for genomic research and analysis.

About Xcelris Genomics

Xcelris Genomics is a company based in Ahmedabad (India) founded in 2005. It operates as a B2B. Xcelris Genomics operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Novogene Corporation, among others.

Competitors of Xcelris Genomics

Xcelris Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Novogene Corporation, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dnanexus.com2009Mountain View, United States$472.55M143
Cloud-based genome informatics and data management are provided.
genomics.com2014Oxford, United Kingdom$115.54M–
Genomic risk assessment and prevention platform is provided.
depixus.com2012Paris, France$34.52M–
Single-molecule genetic and epigenetic sequencing solutions are provided.
sevenbridges.com2009Cambridge, United States$113M112
Cloud-based platform to analyze, store, and act on genomic data.
novogene.com2011Beijing, China$75M141
Genomic services and solutions with NGS expertise are provided.
ingenuity.com1998Redwood, United States$20.4M30
Genomic data is analyzed and interpreted via web-based applications.
eaglegenomics.com2008Cambridge, United Kingdom$38.73M–
Developer of cloud-based software solutions for genomic analysis
rejuvenatebio.com2017San Diego, United States$14.58M39
Gene-editing platform and anti-aging therapy for dogs are developed.
sourcebioscience.com1903Nottingham, United Kingdom–273
Multiple genomic services are provided for analysis and diagnostics.
Premium access

Detailed competitors of Xcelris Genomics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Xcelris Genomics

Websites that share an audience with Xcelris Genomics (xcelrisgenomics.com).

Similar websites

Websites whose visitors overlap most with Xcelris Genomics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
scigenom.com
100%
1.3K#14,077,303View details

Latest news on Xcelris Genomics

Premium access

Complete news archive for Xcelris Genomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Xcelris Genomics

10 companies that operate in the same segment as Xcelris Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Xcelris Genomics

Xcelris Genomics was founded in 2005.

Xcelris Genomics is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Xcelris Genomics delivers comprehensive services for genomic research and analysis through providing healthcare solutions, advancing biotech innovations, genomic research, and research services. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Xcelris Genomics's top competitors include DNAnexus, Novogene Corporation and Eagle Genomics.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available